Related Experiment Video
Updated: Sep 20, 2026

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library
Published on: September 30, 2019
Identification of a murine ICAM-1-specific peptide by subtractive phage library selection on cells
Anna-Karine Bélizaire1, Lioudmila Tchistiakova, Yves St-Pierre
1Supratek Pharma Inc. Laval, QC, Canada.
Insights
Researchers identified a novel peptide targeting intercellular adhesion molecule-1 (ICAM-1) on dysfunctional endothelial cells. This peptide, when part of a larger protein, can inhibit ICAM-1-mediated adhesion, offering potential for targeted therapies.
Area of Science:
- Biochemistry
- Molecular Biology
- Immunology
Background:
- Intercellular Adhesion Molecule-1 (ICAM-1) is expressed at low levels on healthy endothelial cells.
- ICAM-1 is significantly upregulated in conditions like inflammation, cancer, and atherosclerosis, indicating cellular dysfunction.
Purpose of the Study:
- To identify novel peptide sequences that specifically bind to the extracellular domain of murine ICAM-1 (mICAM-1).
- To evaluate the potential of these peptides as targeting vectors for dysfunctional endothelium.
- To assess the efficacy of a chimeric protein incorporating the peptide in inhibiting ICAM-1-mediated adhesion.
Main Methods:
- Screening of a phage display library using COS-7 cells expressing mICAM-1 as a target.
- Selection of clones via elution with a monoclonal antibody (mAb) specific for a functional ICAM-1 epitope.
- Incorporation of the identified peptide into a chimeric protein and assessment of its inhibitory effect on ICAM-1-mediated adhesion.
Main Results:
- A novel peptide sequence with binding affinity for the extracellular domain of mICAM-1 was identified.
- The targeting specificity of the peptide was maintained when incorporated into a chimeric protein.
- The chimeric protein demonstrated inhibition of ICAM-1-mediated intercellular adhesion during antigen presentation.
Conclusions:
- The identified peptide serves as a potential targeting vector for dysfunctional endothelium.
- Chimeric proteins incorporating this peptide can modulate ICAM-1-mediated cell-cell interactions.
- These findings highlight the potential for developing targeted therapeutic agents for diseases involving adhesion molecules.
Abstract:
The ICAM-1 adhesion molecule is expressed selectively at low levels on endothelial cells but is strongly upregulated in dysfunctional endothelial cells associated with inflammation, cancer, and atherogenesis. Using COS-7 cells transfected with murine ICAM-1 (mICAM-1) as a target receptor, a phage display library was screened. Clones were selected by elution with a mAb specific for a functional epitope of ICAM-1 and a novel peptide sequence binding to the extracellular domain of mICAM-1 was identified that can potentially be used as a targeting vector aimed at dysfunctional endothelium. We further showed that the targeting specificity of the peptide was retained following its incorporation at the N terminal end of a large chimeric protein. Moreover, this chimeric protein containing the mICAM-1-specific sequence was found to inhibit ICAM-1-mediated intercellular adhesion during antigen presentation. Taken together, these results demonstrate the potential for improving the cell-selectivity and properties of therapeutical agents toward targeting adhesion molecules involved in cell-cell interactions.

